It was concluded that this micelleplex can improve the therapeutic efficacy in vitro and in vivo, overcoming the efflux of drug out of the tumor cell, by decreasing the gene expression of P-glycoprotein and consequently promoting an increase in the concentration of Dox inside the tumor. Here, ABCB1 is linked to neoplasm.